Medically reviewed by Doru Paul, MD To confirm a psoriasis diagnosis, your healthcare provider will check your skin and scalp ...

Plaque psoriasis is characterized by raised ... require treating the underlying inflammation with a systemic drug. Scalp psoriasis shows up as itchy, scaly patches on the scalp that may bleed ...

And beyond the physical symptoms, plaque psoriasis also frequently has negative effects on mental health and alters the lifestyle of those living with it. Here are five ways that this skin condition ...

Researchers conducted a retrospective study to investigate the effectiveness of brodalumab for treating difficult-to-manage ...

Lesions may affect the face, ears, and scalp, but the palms and soles ... Guttate psoriasis may represent the initial stage of chronic plaque-type psoriasis. On resolution, post-inflammatory ...

It’s commonly found on the elbows, knees or scalp but can occur nearly ... Common types of psoriasis include: • Plaque psoriasis – This most common type appears as raised, red skin patches ...

Guselkumab achieved clear or almost clear skin in 74.2% of patients with moderate plaque psoriasis, compared to 12.4% on placebo. The VISIBLE study showed rapid and significant clearance of scalp ...

Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low BSA moderate PsO with involvement across four special sites (scalp, face, skin folds ...

At week 16, an IGA score of 0 or 1 was met for guselkumab vs placebo in scalp (75.0% vs 14.5% ... with low body surface area (BSA) moderate plaque psoriasis (PsO) found the treatment significantly ...

Though psoriasis affects people of all skin ... that is dedicated to people of color that are living with plaque psoriasis and scalp psoriasis, with the sole intent to address these gaps in ...

(RTTNews) - Johnson & Johnson (JNJ) Friday announced positive results from Phase 3b SPECTREM study of Tremfya to treat adults with low body surface area (BSA) moderate plaque psoriasis (PsO ...

moderate plaque psoriasis (PsO) with special site involvement who had failed topical treatment. Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low ...